Solid Biosciences (SLDB) Net Cash Flow (2017 - 2024)
Historic Net Cash Flow for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to $15.9 million.
- Solid Biosciences' Net Cash Flow fell 3649.61% to $15.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.3 million, marking a year-over-year increase of 10754.77%. This contributed to the annual value of $6.3 million for FY2024, which is 10779.04% up from last year.
- Per Solid Biosciences' latest filing, its Net Cash Flow stood at $15.9 million for Q4 2024, which was down 3649.61% from -$31.4 million recorded in Q3 2024.
- Solid Biosciences' Net Cash Flow's 5-year high stood at $113.8 million during Q1 2021, with a 5-year trough of -$90.9 million in Q3 2021.
- For the 5-year period, Solid Biosciences' Net Cash Flow averaged around -$6.3 million, with its median value being -$9.1 million (2020).
- In the last 5 years, Solid Biosciences' Net Cash Flow skyrocketed by 103532.24% in 2022 and then crashed by 67036.77% in 2023.
- Over the past 5 years, Solid Biosciences' Net Cash Flow (Quarter) stood at $1.2 million in 2020, then surged by 651.24% to $9.4 million in 2021, then surged by 1035.32% to $106.4 million in 2022, then tumbled by 76.51% to $25.0 million in 2023, then tumbled by 36.5% to $15.9 million in 2024.
- Its Net Cash Flow stands at $15.9 million for Q4 2024, versus -$31.4 million for Q3 2024 and -$21.6 million for Q2 2024.